EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSAPEG00000023529
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSAPEG00000016631
Gene Symbol: ITGB8
1 Cross references
207 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSAPEG00000023528
Gene Symbol: ITGA5
1 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSAPEG00000018887
Gene Symbol: ITGAV
1 Cross references
236 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSAPEG00000005468
Gene Symbol: ITGB1A
1 Cross references
209 Possible Orthologues:

Integrin, Beta 1b

Ensembl ID : ENSAPEG00000015078
Gene Symbol: ITGB1B
1 Cross references
230 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSAPEG00000013373
Gene Symbol: ITGB5
1 Cross references
211 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSAPEG00000008256
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSAPEG00000021529
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSAPEG00000017839
Gene Symbol: IDH2
1 Cross references
196 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSAPEG00000001016
Gene Symbol: IDH2
1 Cross references
204 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSAPEG00000023223
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).